Postpartum Hemorrhage (PPH) Devices Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product : Global Opportunity Analysis and Industry Forecast, 2021-2030

Postpartum Hemorrhage (PPH) Devices Market Research, 2030

The global postpartum hemorrhage (pph) devices market was valued at $797.32 million in 2020, and is projected to reach $1.3 billion by 2030, growing at a CAGR of 5.3% from 2021 to 2030.

Postpartum hemorrhage (PPH) is one of the leading cause of maternal mortality, which is most common form of obstetric hemorrhage. PPH is blood loss from vagina or cesarean section delivery. Classification of PPH is on the basis of blood loss. Primary PPH is one in which blood loss is less than 500 ml and in secondary PPH blood loss is more than 500ml. Modern PPH treatment devices outpace the traditional methods, due to the fact  that these devices aim toward healing the uterine conditions and problems of uterus contractions. PPH devices are second line intervention devices that are utilized as non-pneumatic anti-shock garment, uterine balloon tamponade, and inject prefilled injection systems. These devices are effective in stopping the blood flow and stabilize the condition of the patient until substantive care is provided.

The key factor that drives the postpartum hemorrhage devices market growth includes increase in complications in pregnancy, including large size baby, inverted uterus, and multiple pregnancies. Moreover, rise in PPH risk factors, such as uterine atony and trauma; growth in anemia cases in pregnant women; and surge in awareness regarding PPH risk factors boost the growth during postpartum hemorrhage devices market forecast. According to report published by the Hindustan times newspaper, on June 2021, women aged between 15 and 49 years suffer with anemia. This rate has increased from 53.1% to 57% and in pregnant women it has increased from 50.4% to 52.2% compared to 2020. According to the report published by journal hindawi on  June 2020, the overall prevalence of anemia among pregnant women was 41% of which 20% were moderately anemic, 18%, mildly anemic, and 3%, severely anemic. According to the report published by BMC Pregnancy and childbirth, article no. 107, in February 2020, PPH is leading obstetric emergency , which causes 25% maternal deaths across the globe. Moreover, increase in number of government  initiatives on education and training regarding PPH propels the growth of this market. Advancement in technology, including capability of the devices to stabilize the condition of the patient until permanent treatment is one of the prominent postpartum hemorrhage devices market trends.There are some restraints for the PPH device market including, high cost of PPH device and scarcity of trained healthcare providers.

Global Postpartum Hemorrhage Devices Market Segmentation

Postpartum hemorrhage devices market size is segmented on the basis of product and region. Product segment is classified into non-pneumatic anti-shock garment, prefilled injection system, and uterine tamponade device. The uterine tamponade segment is fragmented into foley catheter, condom catheter, balloon tamponade, and other. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, Italy, the UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Segment Review

The postpartum hemorrhage (pph) devices market is segmented into region and Product.

Depending on postpartum hemorrhage devices market analysis, among product, the uterine balloon tamponade segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to the property of device that works rapidly and reduces the need for risky and costly surgical operations. Moreover, the device is fast acting and less invasive, which is a safe method for controlling PPH. Furthermore, the device kit has minimal parts thus, it can be assembled easily and in less time, which increases its efficacy.

Region-wise, North America accounted for the largest postpartum hemorrhage devices market share in 2020, and is expected to be dominant during the forecast period, owing to rise in the PPH cases and surge in availability of advanced healthcare facilities.

However, Asia-Pacific is expected to register highest CAGR of 6.4% from 2021 to 2030, owing to increase in number of women affected with anemia in the region, which, in turn, increases the risk of PPH. In addition, rise in awareness about PPH complications among people and increase in healthcare expenditure is providing a lucrative postpartum hemorrhage devices market opportunity for key players.

The major companies profiled in this report include, 3rd Stone Design, Bactiguard AB, Becton, Dickinson and Company  Clinical Innovations, LLC., Cook, Obstetrx, Organon, Path, Teleflex Incorporated, and Utah Medical Products, Inc

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the postpartum hemorrhage devices industry, market segments, current trends, estimations, and dynamics of the postpartum hemorrhage (pph) devices market analysis from 2020 to 2030 to identify the prevailing postpartum hemorrhage devices market opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the postpartum hemorrhage (pph) devices market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global postpartum hemorrhage devices industry, market trends, key players, market segments, application areas, and market growth strategies.

  Postpartum Hemorrhage (PPH) Devices Market Report Highlights

Aspects	Details
Market Size By 2030	USD 1.3 billion
Growth Rate	CAGR of 5.3%
Forecast period	2020 - 2030
Report Pages	205
By Product	Non-Pneumatic Anti-Shock Garment Prefilled Injection System Uterine Tamponade Devices
By Region	North America  (U.S., Canada, Mexico) Europe  (Germany, France, U.K., Italy, Spain, Rest of Europe) Asia-Pacific  (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific) LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players	ORGANON, Bactiguard AB, OBSTETRX, Teleflex Incorporated, PATH, Clinical Innovations, LLC., BD, Utah Medical Products, Inc., Cook, 3rd Stone Design

Analyst Review

This section provides various opinions of top-level CXOs in the postpartum hemorrhage(PPH) devices market. In accordance to several interviews conducted, utilization of PPH devices is expected to witness a significant rise, owing to  increase in complication cases of pregnancy. The PPH devices market has piqued the interest of the healthcare industry, owing to its increasing usage by physician in developed countries. According to the perspectives of CXOs of leading companies in the market increase in risk factors causing PPH and technological advancements drive the growth of the global  PPH devices market. However, high cost of the product and lack of healthcare service providers in developing countries hamper the market growth. Presently, intra uterine balloon tamponade is the most preferred option for PPH prevention. According to the CXOs, rise in risk factors, including uterine atony and trauma and surge in prevalence of anemia gives rise to clotting problems.Therefore, the use of PPH devices rise the clotting problems. Therefore, use of PPH devices is expected to increase in the future. CXOs state that  use of these devices is the highest in  North America, owing to the increase in government expenditure on healthcare, followed by Europe and Asia-Pacific, respectively.

Author Name(s) : Prachi Sanjay Rakshe | Roshan Deshmukh

Related Tags

• Gynecology
• Hemophilia
• Wound Care